Ikarian Capital’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-70,546
Closed -$4.42M 98
2023
Q4
$4.42M Buy
70,546
+40,000
+131% +$2.5M 0.41% 26
2023
Q3
$1.39M Buy
+30,546
New +$1.39M 0.17% 40
2023
Q2
Hold
0
97
2021
Q4
Sell
-27,968
Closed -$3.13M 162
2021
Q3
$3.13M Sell
27,968
-91,743
-77% -$10.3M 0.22% 50
2021
Q2
$19.4M Buy
119,711
+104,627
+694% +$16.9M 1.57% 2
2021
Q1
$1.84M Buy
+15,084
New +$1.84M 0.06% 106
2020
Q4
Hold
0
156
2020
Q3
Hold
0
119
2020
Q2
Hold
0
99
2020
Q1
Hold
0
88
2019
Q4
Hold
0
64